project id: TCGA-STAD; case submitter id: TCGA-VQ-A94P; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.32; rna integrity number: 7.1; age at index: 57; days to birth: -21022; days to death: 81; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1954; year of death: 2011; age at diagnosis: 21022; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C16.2; last known disease status: not reported; morphology: 8490/3; primary diagnosis: Signet ring cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of stomach; synchronous malignancy: No; tissue or organ of origin: Body of stomach; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1039; days to sample procurement: 0; initial weight: 430.0; portion submitter id: TCGA-VQ-A94P-01A-13; percent lymphocyte infiltration: 12.0; percent monocyte infiltration: 1.0; percent necrosis: 1.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 84.0; percent tumor cells: 15.0; percent tumor nuclei: 75.0;